Company Number: SC731814

Analysis Date: 2025-07-19 12:33 UTC

Financial Health Assessment for ARMINNOVATE LTD

---

1. Financial Health Score: B

Explanation:
ARMINNOVATE LTD shows a solid financial footing for a young company incorporated in 2022. Its net current assets and net assets have improved significantly over two years, indicating growing financial stability. The company demonstrates healthy liquidity and an absence of overdue filings or distress signals. However, as a small private limited company in consultancy, it has limited tangible assets and is reliant on shareholder loans, which should be monitored carefully. Overall, it is financially healthy but with room for improved robustness and diversification of funding sources.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£70,434	Healthy short-term resources, showing increased cash and debtors
Cash at Bank	£37,208	Good cash reserves — "healthy cash flow" indicator
Trade Debtors	£17,058	Increase shows good sales but requires cash collection vigilance
Current Liabilities	£27,407	Manageable short-term debts; includes director loans (£18,544)
Net Current Assets	£43,027	Strong working capital, enabling smooth operations
Net Assets / Shareholders' Equity	£44,083	Positive equity base, growing steadily over two years
Tangible Fixed Assets	£1,304	Minimal physical assets typical for consultancy
Provisions for Liabilities (Deferred Tax)	£248	Small deferred tax provision, manageable
Creditors (including director loans)	£27,407	Director loans significant; reliance on internal funding
Number of Employees	2	Small, focused team consistent with company size
Filing Status	Up to date	No overdue filings; good compliance health

---

3. Diagnosis: What the Financial Data Reveals

• Liquidity & Cash Flow: The company exhibits a "healthy cash flow" indicated by a strong cash balance (£37k) relative to liabilities (£27k), suggesting it can comfortably meet short-term obligations. The increase in trade debtors signals growing sales but also a need for efficient credit control to avoid cash flow bottlenecks.

• Solvency & Capital Structure: The positive net assets (£44k) and shareholders’ funds show that the business is solvent and has built equity since incorporation. The reliance on director loans (£18.5k) to finance operations is a symptom of early-stage funding but should be monitored to avoid over-dependence on related parties.

• Asset Base: The company’s tangible assets are minimal (£1.3k), which is typical for a consultancy business that mainly relies on intellectual capital rather than physical assets. This "lean asset" structure reduces fixed costs but may limit borrowing capacity.

• Growth & Stability: The doubling of net current assets and net equity from £13.9k in 2023 to £44k in 2024 signals positive growth and retention of earnings or capital injection, reflecting good operational performance or investment.

• Compliance & Governance: The company is fully compliant with filing deadlines, reducing administrative risk. Directors are experienced professionals with control fairly split, indicating stable governance.

• Risks / Symptoms of Distress:

  • The main caution is the high level of director loans which, while common in start-ups, represents a financial obligation that could affect liquidity if not managed prudently.
  • The small employee base and limited asset diversification mean the company’s fortunes depend strongly on its key directors and client contracts.

---

4. Recommendations for Improving Financial Wellness

1. Strengthen Cash Flow Management:
   Continue to monitor and accelerate collection of trade debtors to maintain liquidity and avoid cash flow pressure.

2. Reduce Reliance on Director Loans:
   Explore alternative funding sources such as bank credit facilities, grants, or equity investment to diversify financing and reduce dependency on shareholder loans.

3. Build Profit Reserves:
   Retain earnings within the business to grow profit and equity reserves, further strengthening the balance sheet and reducing external funding needs.

4. Maintain Filing Discipline:
   Keep on top of all statutory compliance to avoid penalties or reputational damage, which the company is currently doing well.

5. Plan for Growth:
   Consider scaling operations prudently; evaluate if hiring or investment in technology can increase efficiency and revenue without disproportionate cost increases.

6. Risk Management:
   Regularly review key contracts and economic conditions to anticipate any client payment delays or market disruptions that could impact financial health.

---

Medical Analogy Summary

ARMINNOVATE LTD currently enjoys a “healthy pulse” with strong liquidity and growing equity, akin to a patient recovering well after initial treatment. The company shows no alarming “symptoms of distress” such as overdue filings or negative net assets. However, the reliance on director loans is like a temporary intravenous drip—beneficial now but requiring transition to stronger, autonomous health through alternative funding and internal cash generation.

---